Complete Filing Data
Sensei Biotherapeutics, Inc. reported Stockholders Equity of $18.59 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sensei Biotherapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$21.1M | -$30.2M | -$34.1M | -$48.6M | -$36.8M | -$20.1M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $14.0K | $196.0K | $795.0K | -$671.0K | -$333.0K | |
| Operating Income Loss | -$22.3M | -$32.6M | -$37.1M | -$50.2M | -$37.5M | -$19.5M |
| Operating Expenses | $22.3M | $32.6M | $37.1M | $50.2M | $37.5M | $19.5M |
| Net Income Loss Available To Common Stockholders Basic | -$21.1M | -$30.2M | -$34.1M | -$48.6M | -$36.8M | -$20.2M |
| Interest Expense | $32.0K | $90.0K | $144.0K | $219.0K | $670.0K | $1.7M |
| General And Administrative Expense | $11.3M | $13.0M | $18.8M | $19.8M | $15.8M | $7.5M |
| Research And Development Excluding In Process Expense | $11.0M | $18.6M | $18.3M | $30.4M | $21.7M | $11.2M |
| Comprehensive Income Net Of Tax | -$21.1M | -$30.0M | -$33.3M | -$49.3M | -$37.1M | -$20.2M |
| Other Comprehensive Income Loss Net Of Tax | $14.0K | $196.0K | $795.0K | -$671.0K | -$333.0K | |
| Other Nonoperating Income Expense | -$4.0K | -$3.0K | -$215.0K | $36.0K | -$9.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.6M | -$4.9M | -$6.9M | -$7.3M | -$7.1M | -$8.0M | -$7.1M | -$9.4M | -$10.2M | -$13.4M | -$10.5M | -$12.4M | -$9.7M | -$9.8M | -$8.0M | -$5.4M | -$4.9M | -$4.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $8.0K | -$5.0K | $7.0K | $107.0K | $44.0K | $72.0K | $147.0K | $274.0K | $181.0K | $7.0K | -$313.0K | -$566.0K | $32.0K | -$101.0K | ||||
| Operating Income Loss | -$4.9M | -$5.2M | -$7.3M | -$7.8M | -$7.8M | -$8.7M | -$7.7M | -$10.2M | -$11.0M | -$13.9M | -$10.7M | -$12.5M | -$10.3M | -$9.8M | -$8.0M | -$5.4M | -$4.9M | -$4.1M |
| Operating Expenses | $4.9M | $5.2M | $7.3M | $7.8M | $7.8M | $8.7M | $7.7M | $10.2M | $11.0M | $13.9M | $10.7M | $12.5M | $10.3M | $9.8M | $8.0M | $5.4M | $4.9M | $4.1M |
| Net Income Loss Available To Common Stockholders Basic | -$4.6M | -$4.9M | -$6.9M | -$7.3M | -$7.1M | -$8.0M | -$7.1M | -$9.4M | -$10.2M | -$13.4M | -$10.5M | -$12.4M | -$9.7M | -$9.8M | -$8.0M | -$5.4M | -$4.9M | -$4.8M |
| Interest Expense | $6.0K | $10.0K | $13.0K | $21.0K | $24.0K | $28.0K | $33.0K | $38.0K | $42.0K | $10.0K | $172.0K | $243.0K | $214.0K | $147.0K | $3.0K | $3.0K | $3.0K | $1.6M |
| General And Administrative Expense | $2.3M | $2.7M | $3.5M | $3.2M | $3.2M | $3.8M | $3.9M | $5.4M | $5.8M | $4.8M | $4.3M | $5.0M | $3.9M | $3.9M | $4.6M | $1.8M | $1.3M | $1.9M |
| Research And Development Excluding In Process Expense | $2.5M | $2.5M | $3.7M | $4.6M | $4.6M | $4.9M | $3.8M | $4.8M | $5.2M | $9.2M | $6.4M | $7.5M | $6.4M | $5.9M | $3.4M | $3.6M | $2.9M | |
| Comprehensive Income Net Of Tax | -$4.6M | -$4.9M | -$6.9M | -$7.1M | -$7.1M | -$7.9M | -$7.0M | -$9.1M | -$10.0M | -$13.4M | -$10.8M | -$13.0M | -$9.7M | -$9.9M | -$8.0M | -$5.4M | -$4.9M | |
| Other Comprehensive Income Loss Net Of Tax | $8.0K | -$5.0K | $7.0K | $107.0K | $44.0K | $72.0K | $147.0K | $274.0K | $181.0K | $7.0K | -$313.0K | -$566.0K | $32.0K | -$101.0K | ||||
| Other Nonoperating Income Expense | $0.00 | -$1.0K | -$2.0K | $0.00 | $0.00 | -$2.0K | -$225.0K | $68.0K | $9.0K | $20.0K | $15.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $18.6M | $38.4M | $64.9M | $103.4M | $146.5M | -$56.4M | -$68.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $8.7M | $10.0M | $13.0M | $17.8M | $7.2M | $16.6M | $251.0K |
| Retained Earnings Accumulated Deficit | -$283.1M | -$262.1M | -$231.9M | -$197.8M | -$149.2M | -$112.4M | |
| Property Plant And Equipment Net | $82.0K | $417.0K | $1.2M | $2.0M | $4.6M | $1.3M | |
| Liabilities Current | $4.3M | $5.4M | $5.6M | $9.1M | $4.9M | $4.8M | |
| Liabilities And Stockholders Equity | $22.9M | $45.4M | $74.4M | $118.4M | $153.2M | $21.4M | |
| Liabilities | $4.3M | $7.0M | $9.5M | $15.0M | $6.7M | $5.5M | |
| Finance Lease Principal Payments | $790.0K | $811.0K | $761.0K | $629.0K | $255.0K | $41.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.3M | -$3.0M | -$4.8M | $10.6M | -$9.4M | $16.3M | |
| Cash And Cash Equivalents At Carrying Value | $8.7M | $10.0M | $13.0M | $17.8M | $7.2M | $16.6M | |
| Assets Current | $21.5M | $41.9M | $67.3M | $108.6M | $148.5M | $20.1M | |
| Assets | $22.9M | $45.4M | $74.4M | $118.4M | $153.2M | $21.4M | |
| Additional Paid In Capital Common Stock | $301.7M | $300.5M | $297.0M | $302.2M | $296.0M | $56.0M | |
| Accounts Payable And Accrued Liabilities Current | $1.5M | $1.2M | $1.7M | $4.5M | $2.5M | $3.9M | |
| Other Assets Current | $92.0K | $120.0K | $325.0K | $344.0K | $374.0K | ||
| Common Stock Value | $0.00 | $0.00 | $3.0K | $3.0K | $3.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0K | -$13.0K | -$209.0K | -$1.0M | -$333.0K | ||
| Other Assets Noncurrent | $18.0K | $48.0K | $86.0K | $63.0K | $39.0K | $86.0K | |
| Finance Lease Liability Noncurrent | $0.00 | $98.0K | $768.0K | $1.6M | $1.7M | $86.0K | |
| Finance Lease Liability Current | $80.0K | $732.0K | $872.0K | $880.0K | $680.0K | $32.0K | |
| Employee Related Liabilities Current | $1.3M | $1.9M | $1.5M | $2.5M | $1.8M | $916.0K | |
| Available For Sale Securities Debt Securities Current | $12.5M | $31.3M | $52.7M | $89.3M | $140.5M | ||
| Accretion On Marketable Securities | -$699.0K | -$986.0K | -$1.1M | $231.0K | $615.0K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $1.5M | $1.6M | $1.4M | $1.2M | |||
| Operating Lease Right Of Use Asset | $1.3M | $2.8M | $4.3M | $5.4M | |||
| Operating Lease Liability Noncurrent | $59.0K | $1.4M | $3.0M | $4.3M | |||
| Operating Lease Liability Current | $1.4M | $1.6M | $1.6M | $1.3M | |||
| Finance Lease Right Of Use Asset Amortization | $17.0K | $771.0K | $780.0K | $733.0K | |||
| Finance Lease Right Of Use Asset | $1.0K | $163.0K | $1.5M | $2.3M | |||
| Other Liabilities Noncurrent | $67.0K | $149.0K | $52.0K | ||||
| Initial Measurement Of Operating Lease Right Of Use Assets | $0.00 | $28.0K | $331.0K | $6.5M | |||
| Initial Measurement Of Operating Lease Liabilities | $0.00 | $28.0K | $331.0K | $6.7M | |||
| Gain Loss On Disposition Of Assets1 | -$302.0K | ||||||
| Issuance Of Equity In Exchange For Compensation Included In Compensation And Employee Benefits | $0.00 | $293.0K | $302.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $23.0M | $27.3M | $32.0M | $45.8M | $52.2M | $58.5M | $71.0M | $79.2M | $94.9M | $114.0M | $125.9M | $135.3M | $155.2M | $163.1M | $171.3M | -$51.7M | -$47.1M | -$42.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $10.6M | $12.6M | $9.9M | $19.1M | $11.9M | $11.0M | $11.3M | $10.2M | $8.1M | $11.5M | $9.9M | $8.7M | $9.5M | $15.6M | $169.4M | $3.7M | $1.9M | $4.3M | |
| Retained Earnings Accumulated Deficit | -$278.4M | -$273.9M | -$268.9M | -$254.3M | -$247.0M | -$239.9M | -$224.5M | -$217.4M | -$208.0M | -$185.6M | -$172.1M | -$161.6M | -$139.8M | -$130.2M | -$120.4M | ||||
| Property Plant And Equipment Net | $112.0K | $143.0K | $159.0K | $899.0K | $1.0M | $1.1M | $1.3M | $1.5M | $1.8M | $2.2M | $2.1M | $2.2M | $3.1M | $2.1M | $1.7M | ||||
| Liabilities Current | $4.4M | $3.9M | $5.2M | $5.4M | $4.9M | $5.0M | $6.2M | $5.4M | $7.6M | $8.5M | $5.4M | $7.6M | $5.3M | $3.9M | $2.5M | ||||
| Liabilities And Stockholders Equity | $27.6M | $31.8M | $38.3M | $53.3M | $59.8M | $66.7M | $81.7M | $89.6M | $107.9M | $128.8M | $138.0M | $150.0M | $161.2M | $167.7M | $174.5M | ||||
| Liabilities | $4.6M | $4.5M | $6.3M | $7.5M | $7.6M | $8.2M | $10.7M | $10.4M | $13.1M | $14.8M | $12.1M | $14.7M | $6.0M | $4.6M | $3.2M | ||||
| Finance Lease Principal Payments | $211.0K | $199.0K | $186.0K | $133.0K | $7.0K | $10.0K | $10.0K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$117.0K | -$2.1M | -$9.7M | $1.6M | $152.8M | $4.0M | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $10.6M | $12.6M | $9.9M | $19.1M | $11.9M | $11.0M | $11.3M | $10.2M | $8.1M | $11.5M | $9.9M | $8.7M | $9.5M | $15.6M | $169.4M | ||||
| Assets Current | $25.8M | $29.6M | $35.7M | $48.1M | $53.9M | $60.2M | $73.8M | $81.1M | $98.6M | $118.5M | $127.5M | $139.0M | $158.2M | $165.6M | $172.8M | ||||
| Assets | $27.6M | $31.8M | $38.3M | $53.3M | $59.8M | $66.7M | $81.7M | $89.6M | $107.9M | $128.8M | $138.0M | $150.0M | $161.2M | $167.7M | $174.5M | ||||
| Additional Paid In Capital Common Stock | $301.4M | $301.2M | $300.9M | $300.0M | $299.3M | $298.5M | $295.9M | $297.1M | $303.6M | $300.8M | $299.3M | $297.8M | $295.1M | $293.4M | $291.6M | ||||
| Accounts Payable And Accrued Liabilities Current | $1.4M | $1.1M | $2.4M | $1.7M | $1.6M | $2.0M | $2.7M | $2.3M | $4.7M | $4.7M | $2.4M | $5.1M | $3.6M | $2.8M | $2.0M | ||||
| Other Assets Current | $248.0K | $116.0K | $440.0K | $81.0K | $142.0K | $269.0K | $318.0K | $252.0K | $454.0K | $336.0K | $293.0K | $199.0K | $301.0K | $472.0K | $60.0K | ||||
| Common Stock Value | $0.00 | $0.00 | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.0K | -$11.0K | -$6.0K | $14.0K | -$93.0K | -$137.0K | -$402.0K | -$549.0K | -$823.0K | -$1.2M | -$1.2M | -$899.0K | -$69.0K | -$101.0K | |||||
| Other Assets Noncurrent | $18.0K | $24.0K | $24.0K | $87.0K | $87.0K | $86.0K | $86.0K | $86.0K | $81.0K | $45.0K | $45.0K | $39.0K | |||||||
| Finance Lease Liability Noncurrent | $0.00 | $4.0K | $35.0K | $206.0K | $377.0K | $571.0K | $962.0K | $1.2M | $1.3M | $1.7M | $1.7M | $1.8M | |||||||
| Finance Lease Liability Current | $193.0K | $341.0K | $583.0K | $831.0K | $864.0K | $871.0K | $874.0K | $879.0K | $879.0K | $850.0K | $798.0K | $786.0K | |||||||
| Employee Related Liabilities Current | $1.2M | $775.0K | $720.0K | $1.3M | $848.0K | $514.0K | $1.1M | $715.0K | $583.0K | $1.8M | $1.0M | $560.0K | |||||||
| Available For Sale Securities Debt Securities Current | $14.5M | $16.1M | $24.5M | $27.9M | $40.4M | $47.1M | $60.7M | $68.6M | $87.4M | $105.1M | $113.8M | $127.5M | $147.1M | $146.9M | |||||
| Accretion On Marketable Securities | -$257.0K | -$114.0K | -$348.0K | $197.0K | |||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $411.0K | $370.0K | $316.0K | $291.0K | |||||||||||||||
| Operating Lease Right Of Use Asset | $1.7M | $2.0M | $2.4M | $3.2M | $3.6M | $4.0M | $4.7M | $5.0M | $5.3M | $5.7M | $6.0M | $6.3M | |||||||
| Operating Lease Liability Noncurrent | $146.0K | $592.0K | $1.0M | $1.8M | $2.2M | $2.6M | $3.4M | $3.8M | $4.1M | $4.6M | $5.0M | $5.3M | |||||||
| Operating Lease Liability Current | $1.7M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.5M | $1.4M | $1.4M | $1.2M | $1.2M | $1.2M | |||||||
| Finance Lease Right Of Use Asset Amortization | $4.0K | $194.0K | $197.0K | $177.0K | |||||||||||||||
| Finance Lease Right Of Use Asset | $6.0K | $10.0K | $15.0K | $964.0K | $1.2M | $1.4M | $1.7M | $1.9M | $2.1M | $2.4M | $2.4M | $2.6M | |||||||
| Other Liabilities Noncurrent | $67.0K | $68.0K | $67.0K | $72.0K | $34.0K | $0.00 | $777.0K | $109.0K | $182.0K | ||||||||||
| Initial Measurement Of Operating Lease Right Of Use Assets | $258.0K | $6.6M | |||||||||||||||||
| Initial Measurement Of Operating Lease Liabilities | $258.0K | $5.6M | |||||||||||||||||
| Gain Loss On Disposition Of Assets1 | -$1.0K | -$40.0K | $20.0K | $0.00 | $0.00 | -$6.0K | -$191.0K | -$105.0K | |||||||||||
| Issuance Of Equity In Exchange For Compensation Included In Compensation And Employee Benefits | $0.00 | $293.0K | $302.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $122.0K | $551.0K | $571.0K | $614.0K | $685.0K | $209.0K |
| Share Based Compensation | $1.3M | $3.1M | $4.5M | $5.8M | $5.7M | $1.5M |
| Payments To Acquire Property Plant And Equipment | $16.0K | $146.0K | $180.0K | $321.0K | $2.0M | $1.2M |
| Net Cash Provided By Used In Operating Activities | -$20.5M | -$24.7M | -$32.0M | -$39.0M | -$30.3M | -$17.7M |
| Net Cash Provided By Used In Investing Activities | $19.8M | $22.4M | $38.4M | $49.9M | -$143.1M | -$1.4M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $233.0K | -$445.0K | -$2.3M | $2.0M | -$1.4M | $335.0K |
| Net Cash Provided By Used In Financing Activities | -$645.0K | -$787.0K | -$11.2M | -$287.0K | $163.9M | $35.5M |
| Increase Decrease In Other Operating Liabilities | $0.00 | -$67.0K | $65.0K | -$16.0K | $205.0K | $249.0K |
| Payments To Acquire Short Term Investments | $25.2M | $44.6M | $21.1M | $46.9M | $183.7M | |
| Increase Decrease In Prepaid Expense | -$243.0K | -$694.0K | $99.0K | $582.0K | -$828.0K | $1.1M |
| Increase Decrease In Employee Related Liabilities | -$562.0K | $666.0K | -$650.0K | $709.0K | $837.0K | -$271.0K |
| Increase Decrease In Other Operating Assets | -$80.0K | -$244.0K | -$22.0K | -$5.0K | $327.0K | |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $44.7M | $67.2M | $59.6M | $89.3M | $31.0M | |
| Increase Decrease In Operating Lease Liabilities | -$1.6M | -$1.6M | -$1.3M | -$1.1M | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Plan Expense | $5.0K | $34.0K | $48.0K | $136.0K | $80.0K | |
| Proceeds From Sale Of Property Plant And Equipment | $250.0K | $0.00 | $166.0K | $15.0K | $318.0K | |
| Payments Related To Tax Withholding For Share Based Compensation | $3.0K | $10.0K | $76.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $30.0K | $140.0K | $135.0K | $137.0K | $137.0K | $138.0K | $161.0K | $151.0K | $144.0K | $157.0K | $136.0K | $122.0K | $98.0K | $64.0K | $52.0K | $23.0K | |
| Share Based Compensation | $461.0K | $1.2M | $1.2M | $1.5M | $1.3M | $194.0K | |||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $37.0K | $151.0K | $19.0K | $487.0K | $52.0K | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$7.1M | -$7.6M | -$11.7M | -$10.8M | -$10.8M | -$6.5M | |||||||||||
| Net Cash Provided By Used In Investing Activities | $7.2M | $5.8M | $2.3M | $12.2M | -$487.0K | -$52.0K | |||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.1M | $306.0K | $242.0K | $2.6M | -$1.9M | -$1.1M | |||||||||||
| Net Cash Provided By Used In Financing Activities | -$214.0K | -$209.0K | -$262.0K | $119.0K | $164.1M | $10.6M | |||||||||||
| Increase Decrease In Other Operating Liabilities | $0.00 | $1.0K | $36.0K | -$15.0K | $52.0K | -$602.0K | |||||||||||
| Payments To Acquire Short Term Investments | $6.3M | $6.3M | $9.8M | $8.0M | |||||||||||||
| Increase Decrease In Prepaid Expense | $438.0K | $716.0K | $1.6M | $2.0M | $2.0M | ||||||||||||
| Increase Decrease In Employee Related Liabilities | -$1.2M | -$703.0K | -$1.6M | -$1.2M | -$475.0K | ||||||||||||
| Increase Decrease In Other Operating Assets | -$57.0K | -$56.0K | $8.0K | -$175.0K | -$50.0K | ||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $13.5M | $12.1M | $12.3M | $7.9M | |||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$424.0K | -$371.0K | -$307.0K | -$271.0K | |||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Plan Expense | $5.0K | $21.0K | $31.0K | $60.0K | $14.0K | ||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $40.0K | $9.0K | |||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $3.0K | $10.0K | $76.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$16.72 | -$24.01 | -$1.22 | -$1.58 | -$1.33 | -$12.53 |
| Common Stock Shares Authorized | 12.5M | 12.5M | 250.0M | 250.0M | 250.0M | 250.0M |
| Weighted Average Number Of Shares Outstanding Basic | 1.3M | 1.3M | 28.0M | 30.7M | 27.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 1.3M | 1.3M | 28.0M | 30.7M | 27.7M | |
| Earnings Per Share Basic | $-16.72 | $-24.01 | $-1.22 | $-1.58 | $-1.33 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 1.3M | 1.3M | 25.0M | 30.8M | 30.6M | 1.9M |
| Common Stock Shares Issued | 1.3M | 1.3M | 25.0M | 30.8M | 30.6M | 1.9M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.62 | -$3.91 | -$0.27 | -$5.77 | -$5.69 | -$0.32 | -$0.28 | -$0.31 | -$0.33 | -$0.44 | -$0.34 | -$0.40 | -$0.32 | -$0.32 | -$0.42 | -$3.00 | -$3.02 | -$4.00 |
| Common Stock Shares Authorized | 12.5M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 1.23B | 1.23B | 1.23B | ||||
| Weighted Average Number Of Shares Outstanding Basic | 1.3M | 1.3M | 25.2M | 1.3M | 1.3M | 25.0M | 25.5M | 30.5M | 30.9M | 30.7M | 30.7M | 30.6M | 30.6M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.3M | 1.3M | 25.2M | 1.3M | 1.3M | 25.0M | 25.5M | 30.5M | 30.9M | 30.7M | 30.7M | 30.6M | 30.6M | |||||
| Earnings Per Share Basic | $-3.62 | $-3.91 | $-0.27 | $-5.77 | $-5.69 | $-0.32 | $-0.28 | $-0.31 | $-0.33 | $-0.44 | $-0.34 | $-0.40 | $-0.32 | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 1.3M | 1.3M | 25.2M | 25.2M | 25.1M | 25.1M | 25.0M | 26.6M | 31.0M | 30.7M | 30.7M | 30.7M | 30.6M | 30.6M | 30.6M | |||
| Common Stock Shares Issued | 1.3M | 1.3M | 25.2M | 25.2M | 25.1M | 25.1M | 25.0M | 26.6M | 31.0M | 30.7M | 30.7M | 30.7M | 30.6M | 30.6M | 30.6M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $3.1M | $4.5M | $5.8M | $5.7M | $1.5M |
| Investment Income Net | $1.2M | $2.6M | $3.6M | $1.8M | $800.0K | |
| Prepaid Expense Current | $231.0K | $474.0K | $1.2M | $1.1M | $547.0K | $1.4M |
| Employee Stock Purchase Plan Expense | $5.0K | $34.0K | $48.0K | $104.0K | $80.0K | |
| Stock Issued During Period Value Surrender Of Shares For Tax Withholding | -3.0K | -10.0K | -76.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $254.0K | $264.0K | $461.0K | $733.0K | $795.0K | $1.2M | $1.0M | $1.1M | $1.2M | $1.5M | $1.4M | $1.5M | $1.7M | $1.7M | $1.3M | $781.0K | $163.0K | $194.0K |
| Investment Income Net | $289.0K | $321.0K | $405.0K | $591.0K | $669.0K | $768.0K | $877.0K | $952.0K | $969.0K | $515.0K | $349.0K | $310.0K | $278.0K | $188.0K | ||||
| Prepaid Expense Current | $496.0K | $828.0K | $911.0K | $1.0M | $1.5M | $1.9M | $1.5M | $2.0M | $2.6M | $1.6M | $3.5M | $2.6M | $1.2M | $2.6M | $3.3M | |||
| Employee Stock Purchase Plan Expense | $14.0K | |||||||||||||||||
| Stock Issued During Period Value Surrender Of Shares For Tax Withholding | -3.0K | -10.0K | -76.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.